Bio-Techne Corp. Stock
Price
Target price
€49.80
€49.80
-1.220%
-0.6
-1.220%
€60.82
04.03.26 / Tradegate
WKN: A12ENG / Symbol: TECH / Name: Bio-Techne / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bio-Techne Corp. Stock
We can see a decrease in the price for Bio-Techne Corp.. Compared to yesterday it has lost -€0.600 (-1.220%).
With 22 Buy predictions and not a single Sell prediction Bio-Techne Corp. is an absolute favorite of our community.
With a target price of 60 € there is a positive potential of 20.48% for Bio-Techne Corp. compared to the current price of 49.8 €.
So far the community has only identified positive things for Bio-Techne Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | -1.220% | 1.633% | -11.071% | -14.138% | -0.400% | -31.310% | - |
| Haemonetics Corp. | 0.910% | 7.619% | 1.802% | - | -17.518% | - | - |
| Bio-Rad Labs Inc. A | 0.790% | 1.840% | -8.537% | -3.647% | -9.849% | -49.741% | -51.360% |
| Neogen Corp. | -10.270% | -12.500% | -8.197% | -7.182% | 36.585% | - | - |
Comments
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $76.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for TECH provided by MarketBeat